Cargando…
A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101335/ https://www.ncbi.nlm.nih.gov/pubmed/33957951 http://dx.doi.org/10.1186/s13054-021-03589-3 |
| _version_ | 1783688944236363776 |
|---|---|
| author | Pascreau, Tiffany Tcherakian, Colas Zuber, Benjamin Farfour, Eric Vasse, Marc Lassalle, Philippe |
| author_facet | Pascreau, Tiffany Tcherakian, Colas Zuber, Benjamin Farfour, Eric Vasse, Marc Lassalle, Philippe |
| author_sort | Pascreau, Tiffany |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8101335 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81013352021-05-07 A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome Pascreau, Tiffany Tcherakian, Colas Zuber, Benjamin Farfour, Eric Vasse, Marc Lassalle, Philippe Crit Care Research Letter BioMed Central 2021-05-06 /pmc/articles/PMC8101335/ /pubmed/33957951 http://dx.doi.org/10.1186/s13054-021-03589-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Research Letter Pascreau, Tiffany Tcherakian, Colas Zuber, Benjamin Farfour, Eric Vasse, Marc Lassalle, Philippe A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title | A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title_full | A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title_fullStr | A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title_full_unstemmed | A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title_short | A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome |
| title_sort | high blood endocan profile during covid-19 distinguishes moderate from severe acute respiratory distress syndrome |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101335/ https://www.ncbi.nlm.nih.gov/pubmed/33957951 http://dx.doi.org/10.1186/s13054-021-03589-3 |
| work_keys_str_mv | AT pascreautiffany ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT tcherakiancolas ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT zuberbenjamin ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT farfoureric ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT vassemarc ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT lassallephilippe ahighbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT pascreautiffany highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT tcherakiancolas highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT zuberbenjamin highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT farfoureric highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT vassemarc highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome AT lassallephilippe highbloodendocanprofileduringcovid19distinguishesmoderatefromsevereacuterespiratorydistresssyndrome |